Medicines losing patent protection

MonthYear

September 2026

1 medicine lost its last listed patent or exclusivity in September 2026.

Sep 28Spryceldasatinib · Bristol Myers Squibb Co

Dates are the patent and exclusivity end dates listed in the FDA's Orange Book, in its data up to October 9, 2026. Patents can be extended, challenged in court or settled, so a generic may come earlier, later or not at all. This is not legal or medical advice.

About the data·Privacy·Credits